Defense stocks are still a funding story, not a crowded trade
Defense has rerated since 2022, but the case for the group is getting stronger, not thinner, because spending pressure is broadening into formal multi-year commitments across the U.S. and allied governments. That matters now because this week’s headlines are less about a one-day fear bid and more about procurement visibility that can keep backlog, guidance, and earnings support intact.
The market keeps asking whether defense has become too crowded to own. We think that frames the sector the wrong way. The more important shift is that defense is no longer trading mainly as a geopolitical panic hedge; it is increasingly trading as a funding story backed by budget pressure, replenishment cycles, and visible order books. This week’s push for higher allied spending in Europe and Asia, alongside a larger U.S. military investment posture, reinforces that the demand signal is widening rather than fading.
That distinction matters because crowded trades usually depend on sentiment staying hot. Funding stories depend on appropriations, procurement, and backlog conversion. The latest policy backdrop looks much closer to the second camp. Public comments this week pointed to pressure on European NATO allies and Canada to add air and naval capacity, while Asian allies were pushed toward defense spending at 3.5% of GDP alongside a $1.5 trillion U.S. military investment posture. That is not the language of a short-lived headline spike; it is the language of a multi-year capex cycle for governments.
The company-level evidence lines up with that view. Lockheed Martin ended the first quarter with a backlog of $186.4 billion and reaffirmed full-year guidance. RTX reported a record $271 billion backlog and raised its 2026 EPS guide to $6.70-$6.90 from $6.60-$6.80. General Dynamics posted roughly 2x billings in Q1 order activity, with total estimated contract value reaching a record $188 billion, up 33% year over year, and it lifted 2026 EPS guidance as well. Those are not the fingerprints of a sector being held up only by fear; they are the fingerprints of customers placing long-duration orders and management teams gaining confidence in delivery.
The breadth of that order support is exactly why the "crowded trade" argument feels overstated. If this were just one hot program or one war-driven scramble, the evidence would be narrow. Instead, the order books are spread across the majors:
RTX: $271 billion backlog, with 2026 EPS guidance raised to $6.70-$6.90
GD: $188 billion estimated contract value, up 33% year over year, with bookings around 2x billings
LMT: $186.4 billion backlog and full-year guidance reaffirmed
NOC: $96 billion backlog, described as more than two years of sales coverage
That kind of dispersion matters. It says the spending case is not isolated to one prime contractor or one product category. It is broad enough to support the thesis that defense is moving from event trade to earnings-visibility trade.
Valuation also looks more nuanced than the bear case admits. Yes, parts of the group have rerated. RTX at 33.9x earnings and LMT at 25.4x are not bargain-bin multiples. But the same sector also includes NOC at 17.1x and GD at 21.7x, while the ETF wrapper ITA is up just 3.8% year to date. That is not what a uniformly euphoric, indiscriminate stampede looks like. It looks like a market paying up for some execution stories while still assigning more measured multiples to cash-generative names with visible demand.
Bulls should not ignore the real risks. There is a legitimate argument that if geopolitical urgency cools, some of the premium multiple names could see compression, and policy pressure on dividends, buybacks, or executive pay could dull part of the sector's traditional shareholder-return appeal. But that critique misses the bigger point: the current setup is less dependent on a fresh shock than it was in 2022. Northrop Grumman raising capex guidance to $1.85 billion for 2026, including $200 million for B-21 capacity, is not how companies behave when they think demand is fleeting. They invest like that when they expect the budget window to stay open.
There is also a historical lesson here. The durable gains in defense have rarely come from the first fear trade alone; they have come when stockpile depletion, force modernization, and alliance commitments turned into procurement programs. That is the more relevant analog now. After years of underinvestment in parts of the Western defense base, governments are not just reacting to one conflict headline. They are rebuilding inventories, expanding capacity, and signaling that burden-sharing has to rise. Markets can overpay for that story in spots, but they can also underestimate how long the spending tail lasts once it becomes embedded in budgets.
That is why we would separate Boeing from the core funding case. Its 85.7x earnings multiple and 2.5% net margin reflect a company-specific recovery story more than a clean defense visibility trade. By contrast, the cleaner read-through sits with the primes whose backlog, guidance, and capacity plans are directly tied to procurement momentum. If investors want to argue the sector is crowded, they need to explain why names with multi-year order coverage and improving guidance should suddenly trade like short-duration fear assets.
The better way to think about defense here is not as a late panic hedge, but as an industrial group with unusually strong revenue visibility. The rerating since 2022 is real, yet the funding backdrop is broadening enough that the trade still looks buyable rather than exhausted. When allies are being pushed toward higher spending targets, the U.S. is signaling a larger investment posture, and major contractors are carrying record or near-record backlogs, the burden of proof shifts to the bears.
What would change our mind? A real break in budget follow-through, not just a quieter news cycle. If backlog growth stalled, guidance stopped moving higher, or procurement commitments failed to convert from rhetoric into appropriations, then the sector would look more like a crowded narrative than a durable earnings story. Right now, the evidence still points the other way.
Our take, not advice. This is opinion commentary — informational only, not personalized investment recommendations. Markets carry risk. Do your own research and consider your own situation before any trade.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
